In today’s recent session, 1.02 million shares of the Icecure Medical Ltd (NASDAQ:ICCM) were traded. Most recently the company’s share price was $0.78, and it changed around $0.12 or 18.44% from the last close, which brings the market valuation of the company to $38.71M. ICCM at last check was trading at a discount to its 52-week high of $1.57, offering almost -101.28% off that amount. The share price’s 52-week low was $0.48, which indicates that the recent value has risen by an impressive 38.46% since then. We note from Icecure Medical Ltd’s average daily trading volume that its 10-day average is 0.54 million shares, with the 3-month average coming to 566.93K.
Icecure Medical Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ICCM as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Icecure Medical Ltd is expected to report earnings per share of -0.07 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Icecure Medical Ltd (NASDAQ:ICCM) trade information
Instantly ICCM has been showing a green trend so far today with a performance of 18.44% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.7900 on recent trading dayincreased the stock’s daily price by 1.27%. The company’s shares are currently down -26.94% year-to-date, but still up 37.45% over the last five days. On the other hand, Icecure Medical Ltd (NASDAQ:ICCM) is 28.15% up in the 30-day period. We can see from the shorts that 0.29 million shares have been sold at a short interest cover period of 0.74 day(s).
The consensus price target as assigned by Wall Street analysts is $5.75, which translates to bulls needing to increase their stock price by 86.43% from its current value. Analyst projections state that ICCM is forecast to be at a low of $5.75 and a high of $5.75.
Icecure Medical Ltd (ICCM) estimates and forecasts
Icecure Medical Ltd share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -34.31 percent over the past six months and at a 15.63% annual growth rate that is well above the industry average of 7.80%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 22.20% in revenue this quarter, and will report a decrease of -16.70% in the next quarter. The year-over-year growth rate is expected to be 16.10%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 710k in revenue for the current quarter. 2 analysts expect Icecure Medical Ltd to make 1.29M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 320k and 1.25M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 121.90%. Forecasts for the next quarter put sales growth at 2.80%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -0.26%.
ICCM Dividends
Icecure Medical Ltd’s next quarterly earnings report is expected to be released on 2024-Aug-20.
Icecure Medical Ltd (NASDAQ:ICCM)’s Major holders
RENAISSANCE TECHNOLOGIES LLC, with 0.1421% or 66400.0 shares worth $49136.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
